Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...

CAR2119’s single-infusion approach offers cost and compliance advantages, though its competitors maintain strong commercial ...

Researchers at the Medical University of Vienna have uncovered how a little-studied protein, TRAT1 (T Cell Receptor ...

T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...

Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...

Autoimmune rheumatic diseases (ARDs), such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic ...

Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...

Xoma Royalty and Lava Therapeutics are turning the temperature down, dropping both the cash per share offer and closing cash ...

Novel therapies for certain autoimmune diseases have been developed to end B cell-driven immune attacks on normal tissues.

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein ...

A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...